Vitiligo epidemiological profile and the association with thyroid disease;perfil epidemiológico dos pacientes com vitiligo e sua associação com doenças da tireoide

Anais Brasileiros de Dermatologia

Volumn 86, Issue 2, 2011, Pages 241-248

  Nunes, Daniel Holthausen ^a   Esser, Ligia Maria Hademann ^b  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

Author keywords

Autoimmunity; Thyroid diseases; Vitiligo

Indexed keywords

THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ACROFACIAL VITILIGO; ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FOCAL VITILIGO; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ONSET AGE; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SEGMENTAL VITILIGO; THYROTROPIN BLOOD LEVEL; VITILIGO; VITILIGO VULGARIS;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BRAZIL; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; MIDDLE AGED; VITILIGO; YOUNG ADULT;

EID: 79960181331     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962011000200006     Document Type: Article

References (28)

1. Bellet J.S, Prose N.S. Vitiligo em crianças: uma revisão de classificação, hipóteses sobre patogênese e tratamento. An Bras Dermatol. 2005;80:631-636.
2. Steiner D, Villas R.T, Bedin V, Steiner T, Moraes M.B. Vitiligo. An Bras Dermatol. 2004;79:335-951.
3. Laberge G, Mailloux C.M, Gowan K, Holland P, Bennett D.C, Fain P.R, et al. Early disease onset and increased risk of other autoimmune disease in familial generalized vitiligo. Pigment Cell Res. 2005;18:300-305.
4. Birlea S.A, Fain P.R, Spritz R.A. A Romanian population isolate with high frequency of vitiligo and associated autoimmune diseases. Arch Dermatol. 2008;144:310-316.
5. Barona M.I, Arrunátegui A, Falabella R, Alzate A. An epidemiologic case-control study in a population with vitiligo. J Am Acad Dermatol. 1995;33:621-625.
6. Sehgal V.N, Srivastava G. Vitiligo: compendium of clinico-epidemiological features. Indian J Dermatol Venereol Leprol. 2007;73:149-156.
7. Liu J.B, Li M, Yang S, Gui J.P, Wang H.Y, Du W.H, et al. Clinical profiles of vitiligo in China: an analysis of 3742 patientes. Clin Exp Dermatol. 2005;30:327-331.
8. Onunu A.N, Kubeyinje E.P. Vitiligo in the Nigerian African: a study of 351 patients in Benin City, Nigeria. Int J Dermatol. 2003;42:800-802.
9. Ingordo V, Gentile C, Iannazzone S.S, Cusano F, Naldi L. The 'Epilist' Project: a dermo-epidemiologic study on a representative sample of young Italian males. Prevalence of selected pigmentary lesions. J Eur Acad Dermatol Venereol. 2007;21:1091-1096.
10. Kovacs S.O. Vitiligo. J Am Acad Dermatol. 1998;38:647-666.
11. Daneshpazhooh M, Mostofizadeh G.M, Behjati J, Akhyani M, Robati R.M. Anti-thyroid peroxidase antibody and vitiligo: a controlled study. BMC Dermatol. 2006;10:1-5.
12. Zettinig G, Tanew A, Fischer G, Mayr W, Dudczak R, Weissel M. Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume? Clin Exp Immunol. 2003;131:347-354.
13. Kakourou T, Kanaka-Gantenbein C, Papadopoulou A, Kaloumenou E, Chrousos G.P. Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo. J Am Acad Dermatol. 2005;53:220-223.
14. Huggins R.H, Schwartz R.A, Janniger C.K. Vitiligo. Acta Dermatovenerol Alp Panonica Adriat. 2005;14:137-145.
15. Ařcan O, Koç K, Ersoy L. Clinical characteristics in 113 Turkish vitiligo patients. Acta Dermatovenerol Alp Panonica Adriat. 2008;17:129-132.
16. Gopal K.V, Rama Rao G.R, Kumar Y.H, Appa Rao M.V, Vasudev P; Srikant. Vitiligo: a part of a systemic autoimmune process. Indian J Dermatol Venereol Leprol. 2007;73:162-165.
17. Lacovelli P, Sinagra J.L.M, Vidolin A.P, Marenda S, Capitanio B, Leone G, et al. Relevance of thyroiditis and of other autoimmune disease in children with vitiligo. Dermatology. 2005;210:26-30.
18. Melo M. Tiroidites autoimunes. Acta Med Port. 2006;19:387-394.
19. Bjoro T, Holmen J, Krüger O, Midthjell K, Hunstad K, Schreiner T, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The health study of Nord-Trondelag(HUNT). Eur J Endocrinol. 2000;143:639-647.
20. Ai J, Leonhardt J.M, Heymann W.R. Autoimmune thyroid disease: etiology, pathogenesis, and dermatologic manifestattions. J Am Acad Dermatol. 2003; 48:641-659.
21. Alkhateeb A, Fain P.R, Thody A, Bennett D.C, Spritz R.A. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 2003;16:208-214.
22. Dogra S, Pasard D, Handa S, Kanwar A.J. Late onset vitiligo: A study of 182 patients. In J Dermatol. 2005;44:193-196.
23. Dave S, Thappa D.M, Dsouza M. Clinical predictors of outcome in vitiligo. Indian J Dermatol Venereol Leprol. 2002;68:323-325.
24. Silva C.M.R, Pereira L.B, Gontijo B, Ribeiro G.B. Vitiligo na infancia: caracteristicas clinicas e epidemiologicas. An Bras Dermatol. 2007;82:47-51.
25. Castro C.C.S. Prevalência de psoríase em estudo de 261 pacientes com vitiligo. An Bras Dermatol. 2005;80:489-492.
26. Boisseau-Garsaud A.M, Garsaud P, Calés-Quist D, Hélénon R, Quénéhervé C, Claire R.C. Epidemiology of vitiligo in the French West Indies (Isle of Martinique). Int J Dermatol. 2000;39:18-20.
27. Fernandes N.C, Campos M.M.C. Vitiligo na criança e doença na tireóide. An Bras Dermatol. 2009;84:200-202.
28. Kuhl I.C.P, Weissbluth M.L, Bakos L, Wollmann T.M. Pesquisa de auto-anticorpos e função tireoideana em pacientes portadores de vitiligo e alopécia areata. An Bras Dermatol. 1995;70:421-425.